Literature DB >> 29800999

Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.

H Ballentine Carter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29800999     DOI： 10.1001/jama.2018.4914

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Magnetic Levitation of Personalized Nanoparticle-Protein Corona as an Effective Tool for Cancer Detection.

Authors:  Erica Quagliarini; Luca Digiacomo; Damiano Caputo; Alessandro Coppola; Heinz Amenitsch; Giulio Caracciolo; Daniela Pozzi
Journal:  Nanomaterials (Basel)       Date:  2022-04-19       Impact factor: 5.719

2.  Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial.

Authors:  Glenn R Cunningham; Susan S Ellenberg; Shalender Bhasin; Alvin M Matsumoto; J Kellogg Parsons; Peter Preston; Jane A Cauley; Thomas M Gill; Ronald S Swerdloff; Christina Wang; Kristine E Ensrud; Cora E Lewis; Marco Pahor; Jill P Crandall; Mark E Molitch; Denise Cifelli; Shehzad Basaria; Susan J Diem; Alisa J Stephens-Shields; Xiaoling Hou; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

3.  The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.

Authors:  Daijun Yang; Xiang Shi; Yu Lei; Xianrong Zhou; Qiuxiang Chen
Journal:  Oncol Lett       Date:  2020-05-21       Impact factor: 2.967

4.  Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression.

Authors:  Dong Chen; Xinxing Lu; Feiya Yang; Nianzeng Xing
Journal:  Cancer Manag Res       Date:  2019-02-12       Impact factor: 3.989

5.  ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.

Authors:  S Tuck; J Long; T Green; A Green; P Ellis; S Green; A Haire; C Moss; F Cahill; N McCartan; L Brown; A Santaolalla; T Marsden; M Rodriquez Justo; J Hadley; S Punwani; G Attard; H Ahmed; C M Moore; M Emberton; M Van Hemelrijck
Journal:  Res Involv Engagem       Date:  2021-11-17

6.  Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.

Authors:  Yongheng Zhou; Wenqiang Qi; Jianfeng Cui; Minglei Zhong; Guangda Lv; Sifeng Qu; Shouzhen Chen; Rongyang Li; Benkang Shi; Yaofeng Zhu
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

7.  Clinical value of prostate-specific antigen combined with tumor abnormal protein (TAP) in the diagnosis of prostate puncture.

Authors:  Yu Guan; Shuiping Yin; Chaozhao Liang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.